Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii

Wroclaw 53-413

0 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia, Advanced BRAFV600 Wild-type Melanoma, High-risk Myelodysplastic Syndrome, Melanoma, Metastatic Prostate Cancer

Studies at this site

• A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma — Completed
• Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer — Completed
• RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome — Status unconfirmed
• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early